HB 6 substantially rewrites Texas law governing consumable hemp products and hemp-derived cannabinoids. The bill narrows the products that may be manufactured and sold by allowing only consumable hemp products containing cannabidiol (CBD) or cannabigerol (CBG), while prohibiting products containing any other cannabinoid. It creates a product-registration system for manufacturers, a retailer registration requirement, new labeling and QR-code requirements, and mandatory testing and reporting rules. The bill also imposes significant licensing and registration fees, including a $10,000 annual fee for each processing/manufacturing location, a $20,000 annual fee for each retail location, and a $500 fee per product registration.
The bill adds extensive restrictions on packaging, marketing, sales locations, and delivery methods. It prohibits products designed to appeal to minors, misleading packaging that suggests medical use, sales near schools, sales by courier or mail, and the manufacture or sale of consumable hemp products for smoking. It also bars sales to persons under 21, requires age verification, and limits participation by people with recent felony drug convictions. Out-of-state products may be sold only if they meet comparable testing, labeling, and registration requirements and comply with federal law.
HB 6 would also create a broad enforcement and penalty structure. It authorizes the Department of State Health Services to investigate complaints, revoke or suspend licenses and registrations, and impose administrative penalties of up to $10,000 per violation. The bill creates several criminal offenses, including felony offenses for unlicensed manufacture or retail sale, delivery or possession with intent to deliver prohibited hemp products, and falsifying laboratory results. Lesser offenses include misdemeanors for possession, sales to minors, prohibited packaging, school-zone sales, and delivery by mail or courier.
The overall sentiment reflected by the bill text is strongly regulatory and restrictive, indicating a legislative intent to sharply limit the hemp-derived cannabinoid market and increase state oversight. Because there are no committee transcripts or recorded votes provided, there is no direct evidence of debate or support/opposition in the available context. However, the structure of the bill suggests likely support from lawmakers concerned about youth access, product safety, and unregulated intoxicating hemp products, and likely concern from hemp businesses and retailers over the narrow product limits, high fees, and criminal penalties.
The main points of contention likely center on whether the bill effectively regulates unsafe products or instead functions as a near-ban on much of the current hemp retail market. Other likely disputes include the high cost of compliance, the exclusion of cannabinoids beyond CBD and CBG, the criminalization of possession and delivery, and the broad restrictions on packaging, marketing, and sales channels.
HB 6 would amend Chapter 443 of the Health and Safety Code and related provisions to create a much more restrictive framework for consumable hemp products in Texas. It would add new licensing, registration, testing, labeling, and enforcement requirements; repeal several existing provisions; and establish new criminal and administrative penalties. The bill would directly affect hemp processors, manufacturers, retailers, laboratories, and consumers, while also touching law enforcement, the Department of State Health Services, and the Health and Human Services Commission through rulemaking and enforcement duties.
No committee transcripts or vote history were provided, so there is no recorded debate or roll-call evidence to measure sentiment directly. Based on the bill’s text, the measure appears to be driven by a cautious, enforcement-oriented approach to hemp regulation, with an emphasis on consumer protection, youth access prevention, and product control. The likely reaction is mixed: supporters would view it as a public-safety and regulatory measure, while opponents would likely see it as overly burdensome and punitive for a lawful hemp industry.
The most likely areas of contention are the bill’s narrow allowance of only CBD and CBG products, the high licensing and registration fees, and the creation of criminal penalties for possession, delivery, and unlicensed sales. Retailers and manufacturers may object to the product-registration system, QR-code labeling, school-zone and delivery restrictions, and the ban on products attractive to minors or packaged in ways that could be seen as misleading. Public-health and law-enforcement supporters are likely to favor these restrictions as tools to reduce youth access, adulterated products, and unregulated intoxicating hemp items.